USPTO serial 86902020
VIUM
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- BUTLER, MIDGE
- Law office
- DIVISIONAL UNIT
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with VIUM?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
San Mateo, CA
San Mateo, CA
SAN MATEO, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Connie L. Ellerbach
Connie L. Ellerbach FENWICK & WEST LLP801 CALIFORNIA STREETSILICON VALLEY CENTERMOUNTAIN VIEW, CA 94041Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment of rheumatoid arthritis, osteoarthritis, pain, multiple sclerosis, inflammatory disease, cancer, and CNS disorders | ACTIVE | — |
| 042 | Laboratory analysis in the field of genotyping and phenotyping of animals, laboratory animal scientific research and testing; laboratory research in the field of genotyping and phenotyping of animals; scientific laboratory services; scientific research and development; scientific research consulting in the field of genotyping and phenotyping of animals; laboratory animal scientific research and testing and avian egg development and; agrochemicals, pharmaceuticals, biologics, agrochemicals, pharmaceuticals, biologics; biopharmaceutical research design and scientific testing services; pharmaceuticals, biopharmaceuticals, and biologics; pharmaceuticals, and medical devices for the presence of endotoxins; animal medical research and testing services and avian egg development and testing services for the purpose of medical research; research and development of pharmaceuticals, medical devices, biotechnology, and biochemicals; platform as a service (PAAS) featuring computer software platforms for conducting preclinical research in the field of animal and human scientific research and testing and development of pharmaceuticals; medical and scientific research, namely, designing, organizing, conducting, monitoring, and managing clinical and non-clinical trials and studies on pharmaceuticals and medical devices for others; scientific consulting services for others in the field of clinical and non-clinical trials and studies on pharmaceuticals and medical devices; collection, calibration, analysis and reporting of medical and scientific research data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices; scientific research and analysis in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, phenotyping, and genetic profiling; computer hardware and software design; development, updating and maintenance of software and databases; animal and non-clinical pharmaceutical and and clinical and pharmaceuticals and medical devices; scientific research and analysis in the field of pharmacology; advisory services in the field of pharmaceutical drug development, namely, selecting animal and biological research models for use in testing drugs; advisory services in the field of pharmaceutical drug development, namely, selecting biomarkers for use in testing drugs; lead candidate drug optimization services, namely, scientific research in the field of identifying compounds for drug development; providing medical and scientific information in the fields of biochemistry, pharmaceuticals and clinical trials; providing online non-downloadable software for designing, conducting, analyzing, and reporting animal studies | ACTIVE | — |
| 044 | Genetic testing of eggs; Medical services in the fields of pathology, pharmacology, and immunology; medical and psychological counseling; providing medical information and advice in the fields of pathology, pharmacology, and immunology; collection, organization, analysis, and reporting of medical data in connection with clinical trials and studies on medical devices | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Mousera, Inc.
- Other trademarks owned by Mousera, Inc.
- Other trademarks owned by VIUM, INC.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named VIUM
- Prosecution event MAB6 explained
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Nov 4, 2019 | MAB6 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Nov 4, 2019 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Oct 11, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Jun 4, 2019 | EX5G | SOU EXTENSION 5 GRANTED | — |
| Apr 11, 2019 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Apr 4, 2019 | EXT5 | SOU EXTENSION 5 FILED | — |
| Apr 4, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Nov 20, 2018 | NOAC | CORRECTED NOA E-MAILED | — |
| Nov 19, 2018 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Nov 17, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Nov 16, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 16, 2018 | INCD | ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST | — |
| Oct 4, 2018 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Oct 4, 2018 | EX4G | SOU EXTENSION 4 GRANTED | — |
| Oct 4, 2018 | EXT4 | SOU EXTENSION 4 FILED | — |
| Oct 4, 2018 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Oct 4, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 6, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 4, 2018 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Apr 4, 2018 | EXT3 | SOU EXTENSION 3 FILED | — |
| Apr 4, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 6, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Oct 4, 2017 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Oct 4, 2017 | EXT2 | SOU EXTENSION 2 FILED | — |
| Oct 4, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Apr 21, 2017 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Apr 21, 2017 | NOAC | CORRECTED NOA E-MAILED | — |
| Apr 20, 2017 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Apr 20, 2017 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Apr 20, 2017 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 30, 2017 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Mar 30, 2017 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 30, 2017 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Mar 30, 2017 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Oct 4, 2016 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Aug 10, 2016 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Aug 9, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 9, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 20, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 5, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 26, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 23, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 23, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 22, 2016 | ALIE | ASSIGNED TO LIE | — |
| Jun 15, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 2, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 2, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 2, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 25, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 12, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 12, 2016 | NWAP | NEW APPLICATION ENTERED | — |